Iktos announces a collaboration with Curreio, Inc., a Japanese company specializing in structural analysis of biomolecules using cryo-electron microscopy. In this collaboration, Iktos’ de novo generative design technology in combination with Curreio’s state-of-the-art cryo-EM platform will be used to facilitate the rapid and cost-effective design of novel preclinical drug candidates for an undisclosed target. Follow the link for the full press release.